DNA damage, p53 and anticancer therapies.
Milner
J
J
Department of Biology, University of York, UK.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000235:genetics*; D004247:DNA / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics*; D006801:Humans; D009369:Neoplasms / Q000235:genetics; D009690:Nucleic Acid Conformation; D017354:Point Mutation; D011485:Protein Binding; D011487:Protein Conformation; D017384:Sequence Deletion; D013379:Substrate Specificity; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000502:physiology*
D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53; D004247:DNA